Document 0027 DOCN M9650027 TI HIV-1 protease specificity derived from a complex mixture of synthetic substrates. DT 9605 AU Kassel DB; Green MD; Wehbie RS; Swanstrom R; Berman J; Glaxo-Wellcome Research Institute, Research Triangle Park, North; Carolina 27709, USA. SO Anal Biochem. 1995 Jul 1;228(2):259-66. Unique Identifier : AIDSLINE MED/96171046 AB A rapid and semiquantitative method is described for determining the relative kcat/Km for individual peptides in defined substrate mixtures. The method utilizes electrospray ionization/mass spectrometry alone to semiquantitatively determine relative peptide substrate turnover rates. Unlike previous studies, in which chromatographic separation of individual peptide species was required, this mass spectrometric-based method relies strictly on the ability to ionize and detect simultaneously all peptide species in a defined mixture. Differences in the ion intensities of the individual components before and after incubation with protease are used to semiquantitatively determine preferred substrates. This method was used to the identify preferred peptide substrates for HIV-1 protease. Optimal substrates were identified from a defined synthetic peptide substrate mixture based on Ser-Gln-Asn-Tyr-Pro-Ile-Val, where the P1' proline was substituted with 20 naturally occurring amino acids. The hydrophobic residues Leu, Ile, Val, Phe, and Tyr were preferred in addition to Pro at the P1' site. The results were corroborated by performing the more laborious HPLC/Frit-fast atom bombardment/MS analyses. DE Amino Acid Sequence HIV Protease/*METABOLISM Mass Fragmentography Molecular Sequence Data Molecular Weight Substrate Specificity Support, U.S. Gov't, P.H.S. Time Factors JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).